Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems

Manoj Motwani,1 Ronald Pei1,21Motwani LASIK Institute, San Diego, 2Precision Outcome Consultants, Fresno, CA, USAPurpose: To evaluate the efficacy of treating patients with +3.00 diopters (D) to +6.00 D of hyperopia via laser-assisted in situ keratomileusis (LASIK) with the WaveLight Allegretto 400&...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Motwani M, Pei R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/5e2be750bbe1457191272660239cb726
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5e2be750bbe1457191272660239cb726
record_format dspace
spelling oai:doaj.org-article:5e2be750bbe1457191272660239cb7262021-12-02T00:07:12ZTreatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems1177-5483https://doaj.org/article/5e2be750bbe1457191272660239cb7262017-05-01T00:00:00Zhttps://www.dovepress.com/treatment-of-moderate-to-high-hyperopia-with-the-wavelight-allegretto--peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Manoj Motwani,1 Ronald Pei1,21Motwani LASIK Institute, San Diego, 2Precision Outcome Consultants, Fresno, CA, USAPurpose: To evaluate the efficacy of treating patients with +3.00 diopters (D) to +6.00 D of hyperopia via laser-assisted in situ keratomileusis (LASIK) with the WaveLight Allegretto 400 and EX500 excimer laser systems.Setting: Private clinical ophthalmology practice.Patients and methods: This was a retrospective study of patients undergoing LASIK treatments of +3.00 to +6.00 D on two different WaveLight laser systems: 163 eyes on the 400 (Hertz) Hz system and 54 eyes on the 500 Hz system. The duration of follow-up was 6 months postoperation. Data were evaluated for uncorrected distance visual acuity, corrected distance visual acuity (CDVA), spherical equivalents (SEQs), and changes in these parameters (eg, loss of vision, regression over time).Results: Treatment with both lasers was safe and effective, with loss of one line of CDVA in four of 162 eyes using the 400 Hz laser system, and none of the 54 eyes with the 500 Hz laser system. Overall, regression ≥0.75 D from goal at 6 months was observed in 11.7% (19/163) of eyes in the 400 Hz laser group and 9.26% (5/54) of eyes in the 500 Hz laser group (regression ≥0.50 D =77.9% [127/163] and 77.8% [42/54], respectively). The mean SEQ regressions for all eyes with moderate hyperopia were 0.10 and 0.18 D for those with high hyperopia.Conclusions: Both the 400 and 500 Hz excimer laser systems were safe and effective for the LASIK treatment of moderate-to-high hyperopia. The overall rate of regression was low and the amount of regression was relatively small with both systems. Keywords: excimer laser, hyperopia, laser-assisted in situ keratomileusis, LASIK, regressionMotwani MPei RDove Medical PressarticleExcimer laserhyperopialaser-assisted in situ keratomileusisLASIKregressionOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 999-1007 (2017)
institution DOAJ
collection DOAJ
language EN
topic Excimer laser
hyperopia
laser-assisted in situ keratomileusis
LASIK
regression
Ophthalmology
RE1-994
spellingShingle Excimer laser
hyperopia
laser-assisted in situ keratomileusis
LASIK
regression
Ophthalmology
RE1-994
Motwani M
Pei R
Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems
description Manoj Motwani,1 Ronald Pei1,21Motwani LASIK Institute, San Diego, 2Precision Outcome Consultants, Fresno, CA, USAPurpose: To evaluate the efficacy of treating patients with +3.00 diopters (D) to +6.00 D of hyperopia via laser-assisted in situ keratomileusis (LASIK) with the WaveLight Allegretto 400 and EX500 excimer laser systems.Setting: Private clinical ophthalmology practice.Patients and methods: This was a retrospective study of patients undergoing LASIK treatments of +3.00 to +6.00 D on two different WaveLight laser systems: 163 eyes on the 400 (Hertz) Hz system and 54 eyes on the 500 Hz system. The duration of follow-up was 6 months postoperation. Data were evaluated for uncorrected distance visual acuity, corrected distance visual acuity (CDVA), spherical equivalents (SEQs), and changes in these parameters (eg, loss of vision, regression over time).Results: Treatment with both lasers was safe and effective, with loss of one line of CDVA in four of 162 eyes using the 400 Hz laser system, and none of the 54 eyes with the 500 Hz laser system. Overall, regression ≥0.75 D from goal at 6 months was observed in 11.7% (19/163) of eyes in the 400 Hz laser group and 9.26% (5/54) of eyes in the 500 Hz laser group (regression ≥0.50 D =77.9% [127/163] and 77.8% [42/54], respectively). The mean SEQ regressions for all eyes with moderate hyperopia were 0.10 and 0.18 D for those with high hyperopia.Conclusions: Both the 400 and 500 Hz excimer laser systems were safe and effective for the LASIK treatment of moderate-to-high hyperopia. The overall rate of regression was low and the amount of regression was relatively small with both systems. Keywords: excimer laser, hyperopia, laser-assisted in situ keratomileusis, LASIK, regression
format article
author Motwani M
Pei R
author_facet Motwani M
Pei R
author_sort Motwani M
title Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems
title_short Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems
title_full Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems
title_fullStr Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems
title_full_unstemmed Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems
title_sort treatment of moderate-to-high hyperopia with the wavelight allegretto 400 and ex500 excimer laser systems
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/5e2be750bbe1457191272660239cb726
work_keys_str_mv AT motwanim treatmentofmoderatetohighhyperopiawiththewavelightallegretto400andex500excimerlasersystems
AT peir treatmentofmoderatetohighhyperopiawiththewavelightallegretto400andex500excimerlasersystems
_version_ 1718403930739703808